User: Guest  Login
Title:

Response-adapted consolidation with bortezomib after ASCT improves progression-free survival in newly diagnosed multiple myeloma.

Document type:
Journal Article; Letter
Author(s):
Einsele, H; Knop, S; Vogel, M; Müller, J; Kropff, M; Metzner, B; Langer, C; Sayer, H; Jung, W; Dürk, H A; Salwender, H; Wandt, H; Bassermann, F; Gramatzki, M; Rösler, W; Wolf, H-H; Brugger, W; Engelhardt, M; Fischer, T; Liebisch, P; Straka, C
Journal title abbreviation:
Leukemia
Year:
2017
Journal volume:
31
Journal issue:
6
Pages contribution:
1463-1466
Language:
eng
Fulltext / DOI:
doi:10.1038/leu.2017.83
Pubmed ID:
http://view.ncbi.nlm.nih.gov/pubmed/28293022
Print-ISSN:
0887-6924
TUM Institution:
III. Medizinische Klinik und Poliklinik (Hämatologie / Onkologie)
 BibTeX